298 related articles for article (PubMed ID: 28169345)
21. TGF-β1, IL-6, and TNF-α in bronchoalveolar lavage fluid: useful markers for lung cancer?
Chen Z; Xu Z; Sun S; Yu Y; Lv D; Cao C; Deng Z
Sci Rep; 2014 Jul; 4():5595. PubMed ID: 24999009
[TBL] [Abstract][Full Text] [Related]
22. Non-invasive breath analysis of pulmonary nodules.
Peled N; Hakim M; Bunn PA; Miller YE; Kennedy TC; Mattei J; Mitchell JD; Hirsch FR; Haick H
J Thorac Oncol; 2012 Oct; 7(10):1528-33. PubMed ID: 22929969
[TBL] [Abstract][Full Text] [Related]
23. [Comparative study of protein markers in serum and bronchoalveolar lavage fluid from patients with lung cancer by surface-enhanced laser desorption ionization time of flight mass spectrometry].
Zhou JH; Liu GN; Huang SM; Zhong XN; Su H; Zhou Y
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Apr; 34(4):274-7. PubMed ID: 21609611
[TBL] [Abstract][Full Text] [Related]
24. Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma.
Codreanu SG; Hoeksema MD; Slebos RJC; Zimmerman LJ; Rahman SMJ; Li M; Chen SC; Chen H; Eisenberg R; Liebler DC; Massion PP
J Proteome Res; 2017 Sep; 16(9):3266-3276. PubMed ID: 28731711
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical staining for stratifin and OCIAD2 in bronchial washing specimens increases sensitivity for diagnosis of lung cancer.
Itoguchi N; Nakagawa T; Murata Y; Li D; Shiba-Ishii A; Minami Y; Noguchi M
Cytopathology; 2015 Dec; 26(6):354-61. PubMed ID: 25376185
[TBL] [Abstract][Full Text] [Related]
26. The more potential performance of nidogen 2 methylation by tissue or plasma DNA over brichoalveolar lavage DNA in diagnosis of nonsmall cell lung cancer.
Feng X; Xie X; Zheng B; Peng C; Zhou H; Qin J
J Cancer Res Ther; 2018 Jun; 14(Supplement):S341-S346. PubMed ID: 29970687
[TBL] [Abstract][Full Text] [Related]
27. Sputum cytology examination followed by autofluorescence bronchoscopy: a practical way of identifying early stage lung cancer in central airway.
Lam B; Lam SY; Wong MP; Ooi CG; Fong DY; Lam DC; Lai AY; Tam CM; Pang CB; Ip MS; Lam WK
Lung Cancer; 2009 Jun; 64(3):289-94. PubMed ID: 19010567
[TBL] [Abstract][Full Text] [Related]
28. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
[TBL] [Abstract][Full Text] [Related]
29. Differential proteomic analysis of bronchoalveolar lavage fluid from lung transplant patients with and without chronic graft dysfunction.
Kosanam H; Sato M; Batruch I; Smith C; Keshavjee S; Liu M; Diamandis EP
Clin Biochem; 2012 Feb; 45(3):223-30. PubMed ID: 22206736
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic significance of gastrin measurement of bronchoalveolar lavage fluid for lung cancer.
Zhou Q; Yang Z; Yang J; Tian Z; Zhang H
J Surg Oncol; 1992 Jun; 50(2):121-4. PubMed ID: 1317485
[TBL] [Abstract][Full Text] [Related]
31. Gene mutation analysis in non-small cell lung cancer patients using bronchoalveolar lavage fluid and tumor tissue as diagnostic markers.
Li J; Hu YM; Wang Y; Tang XP; Shi WL; Du YJ
Int J Biol Markers; 2014 Dec; 29(4):e328-36. PubMed ID: 24519547
[TBL] [Abstract][Full Text] [Related]
32. Value of CEA and SCC-Ag in bronchoalveolar lavage (BAL) and serum of patients with lung carcinoma.
Nikliński J; Chyczewska E; Furman M; Kowal E; Kozłowski M
Neoplasma; 1992; 39(5):283-5. PubMed ID: 1331827
[TBL] [Abstract][Full Text] [Related]
33. [Application of ThinPrep cytology test in the diagnosis of lung cancer].
Chi Q; Zheng JY; Dai XJ; Zheng YK; Chen SX; Xu HM; Huang XP
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):221-4. PubMed ID: 20450593
[TBL] [Abstract][Full Text] [Related]
34. Napsin A levels in epithelial lining fluid as a diagnostic biomarker of primary lung adenocarcinoma.
Uchida A; Samukawa T; Kumamoto T; Ohshige M; Hatanaka K; Nakamura Y; Mizuno K; Higashimoto I; Sato M; Inoue H
BMC Pulm Med; 2017 Dec; 17(1):195. PubMed ID: 29233112
[TBL] [Abstract][Full Text] [Related]
35. Urinary volatile compounds as biomarkers for lung cancer.
Hanai Y; Shimono K; Matsumura K; Vachani A; Albelda S; Yamazaki K; Beauchamp GK; Oka H
Biosci Biotechnol Biochem; 2012; 76(4):679-84. PubMed ID: 22484930
[TBL] [Abstract][Full Text] [Related]
36. Glycosaminoglycans and glycolipids as potential biomarkers in lung cancer.
Li G; Li L; Joo EJ; Son JW; Kim YJ; Kang JK; Lee KB; Zhang F; Linhardt RJ
Glycoconj J; 2017 Oct; 34(5):661-669. PubMed ID: 28822024
[TBL] [Abstract][Full Text] [Related]
37. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.
Uke M; Rekhi B; Ajit D; Jambhekar NA
Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186
[TBL] [Abstract][Full Text] [Related]
38. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
[TBL] [Abstract][Full Text] [Related]
39. Liquid Profiling in Lung Cancer - Quantification of Extracellular miRNAs in Bronchial Lavage.
Schmidt B; Rehbein G; Fleischhacker M
Adv Exp Med Biol; 2016; 924():33-37. PubMed ID: 27753015
[TBL] [Abstract][Full Text] [Related]
40. Bronchoalveolar lavage fluid of lung cancer patients: mapping the uncharted waters using proteomics technology.
Oumeraci T; Schmidt B; Wolf T; Zapatka M; Pich A; Brors B; Eils R; Fleischhacker M; Schlegelberger B; von Neuhoff N
Lung Cancer; 2011 Apr; 72(1):136-8. PubMed ID: 21334092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
